Adrenaline in the treatment of anaphylaxis: What is the evidence?

Andrew P.C. McLean-Tooke; Claire A. Bethune; Ann C. Fay; Gavin P. Spickett

doi:10.1136/bmj.327.7427.1332

Adrenaline in the treatment of anaphylaxis: What is the evidence?

Andrew P.C. McLean-Tooke^*, Claire A. Bethune, Ann C. Fay, Gavin P. Spickett

^*Corresponding author for this work

Newcastle upon Tyne Hospitals NHS Foundation Trust

Research output: Contribution to journal › Review article › peer-review

Abstract

Adrenaline (epinephrine) is the recommended first line treatment for patients with anaphylaxis. This review discusses the safety and efficacy of adrenaline in the treatment of anaphylaxis in the light of currently available evidence. A pragmatic approach to use of adrenaline auto-injectors is suggested.

Original language	English
Pages (from-to)	1332-1335
Number of pages	4
Journal	British Medical Journal
Volume	327
Issue number	7427
DOIs	https://doi.org/10.1136/bmj.327.7427.1332
Publication status	Published - 6 Dec 2003
Externally published	Yes

ASJC Scopus subject areas

General Medicine

Access to Document

10.1136/bmj.327.7427.1332

Cite this

@article{80229d5f9ba64fcd83d6519b3cd62a55,

title = "Adrenaline in the treatment of anaphylaxis: What is the evidence?",

abstract = "Adrenaline (epinephrine) is the recommended first line treatment for patients with anaphylaxis. This review discusses the safety and efficacy of adrenaline in the treatment of anaphylaxis in the light of currently available evidence. A pragmatic approach to use of adrenaline auto-injectors is suggested.",

author = "McLean-Tooke, {Andrew P.C.} and Bethune, {Claire A.} and Fay, {Ann C.} and Spickett, {Gavin P.}",

year = "2003",

month = dec,

day = "6",

doi = "10.1136/bmj.327.7427.1332",

language = "English",

volume = "327",

pages = "1332--1335",

journal = "British Medical Journal",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

number = "7427",

}

TY - JOUR

T1 - Adrenaline in the treatment of anaphylaxis

T2 - What is the evidence?

AU - McLean-Tooke, Andrew P.C.

AU - Bethune, Claire A.

AU - Fay, Ann C.

AU - Spickett, Gavin P.

PY - 2003/12/6

Y1 - 2003/12/6

N2 - Adrenaline (epinephrine) is the recommended first line treatment for patients with anaphylaxis. This review discusses the safety and efficacy of adrenaline in the treatment of anaphylaxis in the light of currently available evidence. A pragmatic approach to use of adrenaline auto-injectors is suggested.

AB - Adrenaline (epinephrine) is the recommended first line treatment for patients with anaphylaxis. This review discusses the safety and efficacy of adrenaline in the treatment of anaphylaxis in the light of currently available evidence. A pragmatic approach to use of adrenaline auto-injectors is suggested.

UR - http://www.scopus.com/inward/record.url?scp=0345527963&partnerID=8YFLogxK

U2 - 10.1136/bmj.327.7427.1332

DO - 10.1136/bmj.327.7427.1332

M3 - Review article

C2 - 14656845

AN - SCOPUS:0345527963

SN - 0959-8146

VL - 327

SP - 1332

EP - 1335

JO - British Medical Journal

JF - British Medical Journal

IS - 7427

ER -

Adrenaline in the treatment of anaphylaxis: What is the evidence?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this